Status:
RECRUITING
The Use of Smart Devices in Capturing Digital Biomarkers in Eating Disorders
Lead Sponsor:
Univa Health
Conditions:
Eating Disorders
Eligibility:
All Genders
10+ years
Brief Summary
This study aims to explore how smart devices can be used to monitor the health of individuals with eating disorders. Eating disorders are serious mental health conditions that impact both mental and p...
Detailed Description
Eating disorders are complex mental health conditions characterised by abnormal eating habits and distressing thoughts about body weight and shape, significantly impacting both mental and physical hea...
Eligibility Criteria
Inclusion
- All participants must be aged 10 years or older.
- Diagnosed with an eating disorder by a clinician as per the World Health Organization\'s ICD-10 (F50.0 through F50.9) or ICD-11 (6B80 - 6B85; 6B8Y, 6B8Z) classification
- Must have a minimum once weekly in-person clinic physical assessment as part of their current treatment plan at the start of the study participation
- Fluent in English
- Capable of reading and understanding the information sheets and consent forms to provide written informed consent.
- For participants aged between 10 and 16 years, parental consent is required first before offering the opportunity to the child. A parent or legal guardian must also be able to read and understand the information sheets and consent forms to provide written informed consent on behalf of the child under 16 years of age.
Exclusion
- Active substance use such as drug or alcohol misuse
- For alcohol consumption of more than 21 units of alcohol per week (1 unit is equivalent to half a pint of beer (285ml), 25ml of spirits, or one glass of wine)
- Diagnostic coding for current mental and behavioural disorders due to substances (ICD10: F10 through F19; ICD11: QE10 through QE1Z and 6C40 through 6C4H)
- A diagnosis of a neurological disorder, including but not limited to cerebrovascular diseases, either currently or in the past or where the eating disorder for which the participant is being treated is considered aetiologically-secondary to a neurological disorder (e.g. pica secondary to a brain injury).
- A diagnosis of schizophrenia or related psychotic disorder.
- Pregnancy.
- A diagnosis of developmental learning disorder (ICD10 F80.0 through F81.9: ICD11: 6A03) or intellectual disorders (ICD10: F70.0 through F79.9; ICD11 6A00).
Key Trial Info
Start Date :
November 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT06544226
Start Date
November 1 2024
End Date
September 1 2025
Last Update
December 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Liverpool
Liverpool, United Kingdom, L69 3GF